Unichem Gets US Regulator Nod to Sell Prostate Drug

New Delhi: Drug firm Unichem Laboratories has received approval from the US health regulator to market alfuzosin hydrochloride extended release tablets, used in treating prostatic hyperlasia, in the American market. The company has received final approval from the US Food and Drug Administration (USFDA) for alfuzosin hydrochloride extended release tablets, a generic version of Concordia Pharmaceuticals Ins's Uroxatral extended relea...